PET/CT scan using a glucose-tracer medicine to study disease
Part of Cancer, Lungs & breathing clinical trials.
This Phase 3 study tests how well a special PET/CT scan medicine (a slightly modified sugar) helps doctors investigate your condition. The goal is to improve how diseases like cancer, brain disorders, heart problems, or infection/inflammation are evaluated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known or suspected condition where this PET/CT scan is being used (such as cancer, dementia, epilepsy, heart inflammation/viability, or infection/inflammation).
- You (or your guardian) can give written informed consent.
- You can manage the scan logistics and stay still long enough to complete the PET/CT scan.
- If you are able to become pregnant, you must be willing to do pregnancy testing before the scan.
- If you are breastfeeding, you must be willing and able to stop breastfeeding for 12 hours after the scan.
- You must be well enough to tolerate the scan and be able to lie flat during the scan; you must fit the scanner limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This study tests if giving a radioactive sugar drink (instead of an IV) before a PET scan works well for cancer imaging. If you already had a standard PET scan, you may be eligible for a second scan using the oral version.
This study tests whether a special imaging scan using a radioactive sugar (18F-FDG) can help doctors better examine lung cancer tissue during thoracic surgery. You may be offered the scan around the time of your operation to help researchers learn how well it works.
This trial tests a special PET/CT scan to spot early lung cancer by finding specific body processes linked to cancer. It compares scan results in people with lung nodules that are either cancer (lung adenocarcinoma) or likely benign.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.